Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza
Despite national guidelines recommending that all children at high risk for influenza complications receive antiviral treatment, nearly half of these children at high-risk did not receive an antiviral in our study. We identify several factors associated with decreased antiviral treatment that may serve to inform future interventions aiming to improve the care of vulnerable children with influenza.
Authors
- Derek J. Williams (ORCID: https://orcid.org/0000-0003-0295-1240)
- Todd A. Lee (ORCID: https://orcid.org/0000-0003-3619-5367)
- Pei-Wen Lien
- Jyotirmoy Sarker (ORCID: https://orcid.org/0000-0002-2528-5458)
- Carlos Gabriel Grijalva (ORCID: https://orcid.org/0000-0002-2329-7797)
- Abdullah Abdelaziz (ORCID: https://orcid.org/0000-0002-5039-4322)
- James W. Antoon (ORCID: https://orcid.org/0000-0001-6188-2658)
Institutions
- University of Illinois Chicago (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- The Journal of Pediatrics
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1016/j.jpeds.2025.114574
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases